Repligen releases inaugural Sustainability Report demonstrating a commitment to responsibility and transparency as the company embeds sustainability into business decisions and operations.

Transparency can help foster understanding and confidence, which is particularly important to the Repligen mission as a trusted partner in the production of biologic drugs that improve human health worldwide. Repligen regards this inaugural sustainability report as demonstrative of the value we place on transparent communications and our increased emphasis on disclosure around environmental, social and governance (ESG) issues that we believe are most relevant to the company. 

Access the full report